Placeholder Banner

What Will it Take to Bring New Pain Therapies to the Market? A New Season of the I am BIO Podcast Explores

February 28, 2023
Media Contact
Theresa Brady

Spring 2023 Season Takes a Deep Dive Into
Pain Therapies, Artificial Intelligence, FDA’s Accelerated Approvals, and Misinformation


Today, the Biotechnology Innovation Organization (BIO) premieres its new I am BIO podcast season, which tells powerful stories of biotech breakthroughs, the people they help, and the global problems they solve.

“We want the American public to know they can trust science and biotechnology innovations, which are improving and saving lives,” said BIO’s CEO Rachel King. “By sharing our industry’s unique approaches to helping solve some of the world’s most pressing problems, we’re arming our listeners with first-hand insight into the exciting world of biotechnology.”

The season launches with a topic that impacts50 million people in the United States daily –chronic pain–and explores safe and effective treatments and how government policies could hinder new treatment developments.

Each year the podcast releases 12 episodes – six in the spring and six beginning in September. The first half of the season will culminate with an episode on science and health misinformation.

Additional episodes during the spring season will cover:

  • The convergence of artificial intelligence and biotechnology
  • Biotech innovation with CRISPR technology
  • Threats to FDA’s Accelerated Approval program

In 2022, PR Daily named the I AM BIO podcast a finalist for its Social Media & Digital Awards in the podcast category. Listen now on BIO’s website, Apple Podcasts, Google Podcasts, or Spotify.

Discover More
Biotechnology companies are hard at work on the cutting-edge innovations we need, but those breakthroughs are at risk from current tax policy. The Biotechnology Innovation Organization, which represents more than 1,000 biotech companies, thanks…
Mr. Delacourt is a senior litigator and regulatory counselor with more than a decade of experience advising biotech companies WASHINGTON – (March 15, 2023) – The Biotechnology Innovation Organization (BIO) welcomes John Delacourt as Deputy General…
"The ecosystem that allows America to develop groundbreaking new medicines is extremely important to our nation and to patients who depend on biotechnology companies. The recent actions by the FDIC, the Federal Reserve, and Treasury to allow SVB…